Viking Therapeutics (VKTX) News Today $26.01 -0.27 (-1.03%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$26.05 +0.04 (+0.16%) As of 06/20/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VKTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should KnowJune 20 at 8:51 PM | msn.comInstitute for Wealth Management LLC. Purchases 9,735 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Institute for Wealth Management LLC. grew its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 12.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 90,337 shares of the biotJune 19 at 5:42 AM | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by GAMMA Investing LLCGAMMA Investing LLC increased its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 9,209.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 24,392 shares of the biotechnology company's stock after acquiJune 19 at 3:03 AM | marketbeat.comMN Wealth Advisors LLC Has $450,000 Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)MN Wealth Advisors LLC lifted its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 215.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,628 shares of the biotechnology company's stock afterJune 18 at 5:59 AM | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Sold by Handelsbanken Fonder ABHandelsbanken Fonder AB decreased its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 80.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,800 shares of the biotechnology company'sJune 16, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 5.7% - Should You Sell?Viking Therapeutics (NASDAQ:VKTX) Shares Down 5.7% - Should You Sell?June 13, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Holdings Lifted by Compagnie Lombard Odier SCmACompagnie Lombard Odier SCmA increased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 286.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,245 shares of theJune 13, 2025 | marketbeat.comViking Therapeutics (VKTX) Rises on Expected DevelopmentsJune 12, 2025 | insidermonkey.comWe're Hopeful That Viking Therapeutics (NASDAQ:VKTX) Will Use Its Cash WiselyJune 12, 2025 | finance.yahoo.comHarbor Capital Advisors Inc. Sells 14,094 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Harbor Capital Advisors Inc. trimmed its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 10.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 115,189 shares of the biotechnology companyJune 12, 2025 | marketbeat.comViking Therapeutics Target of Unusually High Options Trading (NASDAQ:VKTX)June 12, 2025 | americanbankingnews.comBrokers Issue Forecasts for VKTX FY2026 EarningsJune 12, 2025 | americanbankingnews.comAnalysts Issue Forecasts for VKTX FY2026 EarningsViking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) - Analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Viking Therapeutics in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst S. Seedhouse expects that the biotechnology coJune 11, 2025 | marketbeat.comWesbanco Bank Inc. Purchases 12,000 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Wesbanco Bank Inc. grew its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 101.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,800 shares of the biotechnJune 11, 2025 | marketbeat.comViking Therapeutics Target of Unusually Large Options Trading (NASDAQ:VKTX)Viking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock investors acquired 23,521 call options on the company. This represents an increase of approximately 45% compared to the typical volume of 16,210 call options.June 10, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Up 7.1% - Still a Buy?Viking Therapeutics (NASDAQ:VKTX) Shares Up 7.1% - Still a Buy?June 10, 2025 | marketbeat.comWas Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?June 9, 2025 | msn.com1 Stock Down 34% This Year to Buy and HoldJune 8, 2025 | fool.com39,652 Shares in Viking Therapeutics, Inc. (NASDAQ:VKTX) Bought by RFG Advisory LLCRFG Advisory LLC acquired a new position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 39,652 shares of the biotechnology company's stock, valued at approximately $9June 6, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Given Consensus Rating of "Buy" by AnalystsViking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) has earned an average rating of "Buy" from the fourteen ratings firms that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issJune 6, 2025 | marketbeat.comProfit Investment Management LLC Buys 44,055 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Profit Investment Management LLC raised its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 59.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 117,769 shares of the biotechnology company'sJune 2, 2025 | marketbeat.comDeutsche Bank AG Reduces Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Deutsche Bank AG trimmed its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 70.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,427 shares of the biotechnology company's stock after selling 15,284 sharesJune 2, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires New Shares in Viking Therapeutics, Inc. (NASDAQ:VKTX)MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 10,797 shares of the biotMay 31, 2025 | marketbeat.comPKO Investment Management Joint Stock Co Purchases Shares of 15,000 Viking Therapeutics, Inc. (NASDAQ:VKTX)PKO Investment Management Joint Stock Co purchased a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund purchased 15,000 shares of the biotechnology company's stock, valued at approximately $604,000. SeveMay 30, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Up 3.4% - Here's WhyViking Therapeutics (NASDAQ:VKTX) Trading 3.4% Higher - Should You Buy?May 29, 2025 | marketbeat.comLighthouse Financial LLC Acquires Shares of 14,000 Viking Therapeutics, Inc. (NASDAQ:VKTX)Lighthouse Financial LLC acquired a new position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 14,000 shares of the biotechnology company's stock, valued at approximately $563,000. OMay 29, 2025 | marketbeat.comViking Therapeutics: Obesity Candidates Must Prove Their Edge As Market Matures (Upgrade)May 29, 2025 | seekingalpha.comWoodline Partners LP Raises Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Woodline Partners LP raised its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 46.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 93,294 shares of the biotechnology companMay 27, 2025 | marketbeat.comWaverly Advisors LLC Increases Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Waverly Advisors LLC raised its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 34.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 48,369 shares of the biotechnology company'May 25, 2025 | marketbeat.comCastleark Management LLC Trims Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Castleark Management LLC lessened its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 85.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,978 shares of the biotechnology company's stock aftMay 24, 2025 | marketbeat.comBank of America Corp DE Reduces Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Bank of America Corp DE lowered its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 14.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 361,551 shares of the biotechnology company's stockMay 24, 2025 | marketbeat.comViking Therapeutics: Weight-Loss Story Remains IntactMay 22, 2025 | seekingalpha.comNationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Reduces Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. reduced its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 45.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 267,464 shares of the bioMay 22, 2025 | marketbeat.comViking Therapeutics: A High Potential Biotech Play With Manageable RisksMay 20, 2025 | seekingalpha.comViking Therapeutics: Near-Term Catalysts And Competitor ReadoutsMay 20, 2025 | seekingalpha.comTang Capital Management LLC Grows Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Tang Capital Management LLC lifted its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 166.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 320,000 shares of the biotechnology company's stMay 20, 2025 | marketbeat.comTema Etfs LLC Invests $813,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX)Tema Etfs LLC bought a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 20,215 shares of the biotechnology company's stock, valued at approximatelyMay 20, 2025 | marketbeat.comRaiffeisen Bank International AG Invests $477,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX)Raiffeisen Bank International AG bought a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 12,000 shares of the biotechnology company's stock, valued at approMay 20, 2025 | marketbeat.comBNP Paribas Financial Markets Has $1.88 Million Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)BNP Paribas Financial Markets lessened its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 46.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 46,701 shares of the biotechnology company's stock after selling 40,011 shares duringMay 20, 2025 | marketbeat.comSecond Line Capital LLC Purchases 11,393 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Second Line Capital LLC boosted its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 29.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 49,511 shares of the biotechnology company's stMay 19, 2025 | marketbeat.comRafferty Asset Management LLC Has $10.91 Million Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX)Rafferty Asset Management LLC boosted its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 6.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 271,163 shares of the biotechnology companyMay 19, 2025 | marketbeat.comMan Group plc Boosts Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Man Group plc lifted its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 3,373.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 448,732 shares of the biotechnology company's stockMay 19, 2025 | marketbeat.comSphera Funds Management LTD. Has $4.16 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Sphera Funds Management LTD. lowered its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 22.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 103,270 shares of the biotechnology company's stock afterMay 18, 2025 | marketbeat.comWhy Viking Therapeutics Stock Bumped 3% Higher TodayMay 16, 2025 | fool.comNorthern Trust Corp Increases Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Northern Trust Corp increased its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 11.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 535,984 shares of the biotechnology company'sMay 15, 2025 | marketbeat.comDimensional Fund Advisors LP Has $4.06 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Dimensional Fund Advisors LP lowered its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 9.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 100,762 shares of the biotechnology company's stock after selling 10,394 shares durMay 15, 2025 | marketbeat.comPiper Sandler Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)May 14, 2025 | theglobeandmail.comIntegral Health Asset Management LLC Sells 100,000 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Integral Health Asset Management LLC reduced its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 40.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 150,000 shares of the biotechnology companyMay 14, 2025 | marketbeat.comEnsign Peak Advisors Inc Lowers Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Ensign Peak Advisors Inc decreased its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 8.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 412,656 shares of the bMay 14, 2025 | marketbeat.com2 Monster Stocks in the Making to Buy Now and Hold for 10 YearsMay 13, 2025 | msn.com Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VKTX Media Mentions By Week VKTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼1.190.65▲Average Medical News Sentiment VKTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼516▲VKTX Articles Average Week Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ascendis Pharma A/S News Today Viatris News Today Qiagen News Today Moderna News Today Blueprint Medicines News Today BridgeBio Pharma News Today Roivant Sciences News Today Verona Pharma News Today Revolution Medicines News Today Elanco Animal Health News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 6/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VKTX Stock Free VKTX Stock Alerts